> Investors > 2014 News Releases

2014 News Releases

Keyword Search
 
Category
Year   
DateTitle 
06/11/14ACETO Subsidiary Rising Pharmaceuticals Launches Generic Evoxac(R) Capsules
PORT WASHINGTON, N.Y., June 11, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Rising Pharmaceuticals, Inc. subsidiary has launched Cevimeline Hydrochloride Capsules, 30 mg strength, the generic version of Daiichi Sankyo, Inc.'s Evoxac® Capsules which is used to treat dry mouth associated with Sjögren's Syndrome. Accor... 
Printer Friendly Version
05/28/14ACETO to Present at the Jefferies 2014 Global Healthcare Conference
PORT WASHINGTON, N.Y., May 28, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Salvatore Guccione, President and CEO, will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 in New York City. Event: Jefferies 2014 Global Healthcare Conference Date: ... 
Printer Friendly Version
05/27/14ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R)
PORT WASHINGTON, N.Y., May 27, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generics subsidiary, has launched the 50 mg, 100 mg and 200 mg strengths of Fluconazole Tablets, USP, an FDA approved generic version of Pfizer Inc.'s. Diflucan®. According to IMS Health data, U.S... 
Printer Friendly Version
05/08/14ACETO Reports Third Quarter Fiscal 2014 Financial Results
PORT WASHINGTON, N.Y., May 8, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2014 ended March 31, 2014. Third Quarter Fiscal 2014 versus Third Quarter Fiscal 2013 Net sales of $124.8 million versus $150.9 million, a 17.3% decrease Gross profit of $25.0 million vers... 
Printer Friendly Version
05/08/14ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., May 8, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on June 27, 2014 to shareholders of record as of June 12, 2014. ABOUT ACETO ACETO Corporation, incorpo... 
Printer Friendly Version
04/30/14ACETO Corporation Completes Acquisition of PACK Pharmaceuticals, LLC
Combination Accelerates Business Shift to Higher Margin Finished Dosage Generics Management to Hold Conference Call to Discuss Transaction at 8:30 a.m. on May 1, 2014 PORT WASHINGTON, N.Y., April 30, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its wholly-owned subsidiary, Rising Pharmaceuticals ("RISING"), has close... 
Printer Friendly Version
04/25/14ACETO Corporation Schedules Fiscal 2014 Third Quarter Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., April 25, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the third quarter of fiscal 2014 ended March 31, 2014 after the stock market close on Thursday, May 8, 2014. Management will host a conference call to discuss the operating and financial results at 9:00am ET on Fri... 
Printer Friendly Version
04/03/14ACETO Subsidiary, Rising Pharmaceuticals, Launches the Authorized Generic of Validus' Lotensin HCT(R)
PORT WASHINGTON, N.Y., April 3, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generics subsidiary, is launching the 10/12.5mg, 20/12.5mg and 20/25mg strengths of Benazepril/HCTZ, the authorized generic of Validus' Lotensin HCT®. According to IMS Health data, U.S. market sa... 
Printer Friendly Version
03/27/14ACETO Corporation to Acquire 100% of the Equity Interests of PACK Pharmaceuticals, LLC
Transaction Significantly Strengthens ACETO's Finished Dosage Generics Business PORT WASHINGTON, N.Y., March 27, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its wholly-owned subsidiary Rising Pharmaceuticals, ("RISING") has signed a definitive purchase agreement to acquire 100% of the equity interests of PACK Pharmaceutica... 
Printer Friendly Version
02/26/14ACETO Appoints Carlos Restrepo to Lead Performance Chemicals
PORT WASHINGTON, N.Y., Feb. 26, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has appointed Carlos Restrepo as Senior Vice President, Performance Chemicals, effective February 24, 2014. Mr. Restrepo will report directly to Salvatore J. Guccione, CEO of ACETO. "Carlos is a proven senior-level chemical executive with ext... 
Printer Friendly Version
02/07/14ACETO Corporation Revenue Estimates Incorrectly Reported Due to Third-Party Error
PORT WASHINGTON, N.Y., Feb. 7, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today that financial media outlets are misreporting that the Company missed revenue forecasts by $30.5 million. In fact, second quarter revenues increased 2.2% over the prior year period to $116.5 million. This was $2.7 million below the correct estimate as opp... 
Printer Friendly Version
02/06/14ACETO Reports Second Quarter Fiscal 2014 Financial Results
EPS Increases 41% Year-Over-Year to $0.24 PORT WASHINGTON, N.Y., Feb. 6, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2014 ended December 31, 2013. Second Quarter Fiscal 2014 versus Second Quarter Fiscal 2013 Net sales of $116.5 million versus $114.0 million, a 2.2% ... 
Printer Friendly Version
02/06/14ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., Feb. 6, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on March 28, 2014 to shareholders of record as of March 13, 2014. ABOUT ACETO ACETO Corporation, inco... 
Printer Friendly Version
01/27/14ACETO Corporation Schedules Fiscal 2014 Second Quarter Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Jan. 27, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2014 ended December 31, 2013 after the stock market close on Thursday, February 6, 2014. Management will host a conference call to discuss the operating and financial results at 9:00am E... 
Printer Friendly Version

top